Back to list

Noom

Behavioral-psychology weight-loss app now bundled with GLP-1 prescriptions via Noom Med
Health Tech 📍 New York, NY Founded 2008
Current Valuation
$3.7B
as of 2024-Q2
UNICORN

IPO Outlookrumored

Is Noom going public?
An IPO is rumored, with nothing filed. Noom remains private and the date is not the company's.
What is Noom's valuation in 2026?
Noom is valued at $3.7B as of 2024-Q2, set by its Series F ($540M, May 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Noom filed an S-1?
No public S-1 is on file for Noom as of 08/23/2026; the IPO is rumored.
Who are Noom's investors?
Noom's investors include Silver Lake, Sequoia Capital, Temasek, RRE Ventures, Oak HC/FT, Samsung Ventures and 1 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Noom is a New York-based behavioral-psychology weight-loss app founded in 2008 by Saeju Jeong and Artem Petakov, best known for pairing CBT-style coaching with calorie and habit tracking. The 2021 Series F led by Silver Lake (with Sequoia and Temasek) valued the company at $3.7B on $540M of fresh capital — the high-water mark. In 2024 Geoff Cook succeeded Saeju Jeong as CEO and pivoted Noom into the GLP-1 wave via Noom Med, bundling behavioral coaching with semaglutide/tirzepatide prescription telehealth, which has become the company's fastest-growing surface as Ozempic and Mounjaro adoption explode.

Company Profile

CEO
Geoff Cook
Founded
2008
HQ
New York, NY
Employees
~1000
Total Raised
$624M
Est. Revenue
$1.0B (2023)
Growth
~25% growth in 2023 to ~$1B revenue; pivoted to Noom Med (GLP-1 prescription telehealth) under new CEO Geoff Cook in 2024
Last Round
Series F — $540M (May 2021) · Lead: Silver Lake
IPO Status
rumored

Fundraising Status

Series F · $540M · 5y 3mo ago
rumoredTotal raised $624M

Secondary Market

Implied price / share
$2.98
Open interest
3
Secondary price return by period
Secondary market period returns3-month-58.3%6-month+39.3%1-year+52.8%All-time-95.1%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. The feed’s last-round price for this company is not a plausible per-share figure, so no comparison is shown. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series F$540MMay 2021Silver Lake

Talent Signal

Hiring trend
First snapshot
trend accrues with monthly sweeps
Open roles
9
via careers page
Product-build share
22%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 22% of open roles build product — hiring is concentrated in sales/marketing/ops (4 of 9 open roles are marketing).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month9Aug '26
Open roles by function
Open roles by functionMarketing4Support2Ops & People1Engineering1Research1
product-building   go-to-market / G&A
Staff Software Engineer\<br>\<br>Princeton, New Jersey, United StatesProduct Management, Design & Researchemail SupportFull-Cycle RecruiterNew\<br>\<br>Princeton, New Jersey, United StatesGrowth Product BuilderNew\<br>\<br>Princeton, New Jersey, United StatesBrand Ambassadors
Counted from Noom's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Saeju JeongArtem Petakov

Investors

Silver Lake · Sequoia Capital · Temasek · RRE Ventures · Oak HC/FT · Samsung Ventures · Serena Ventures

Products

  • Noom Weight (behavioral CBT app for weight loss)
  • Noom Med (GLP-1 prescription telehealth)
  • Noom for Diabetes
  • Noom Mood (mental wellness)
  • Noom Family

Competitors

WW International (WW) · Hims & Hers Health (HIMS) · Ro · Calibrate · Found · Eli Lilly Direct (LLY)
TelehealthGLP-1Weight LossConsumer HealthBehavioral Health
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q2. Refreshed quarterly.